NCT03987919 A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT03986502 Financial Navigation Intervention in Improving Financial and Clinical Outcomes in Patients With Newly Diagnosed Gastric or Gastroesophageal Junction Adenocarcinoma Status COMPLETED Phase NA
NCT03963232 A Study of Galcanezumab (LY2951742) in Participants With Episodic Migraine Status COMPLETED Phase PHASE3
NCT03962738 A Study Lasmiditan (LY573144) in a Single Migraine Attack in Japanese Participants With Migraine Status COMPLETED Phase PHASE2
NCT03958136 Clinico-biological Data Collection Study of Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT03955939 A Study of LY3295668 Erbumine in Participants With Breast Cancer That Has Spread to Other Parts of the Body Status COMPLETED Phase PHASE1
NCT03954834 A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone Status COMPLETED Phase PHASE3
NCT03952559 A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03952143 A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT03952130 A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT03951753 A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE1
NCT03944031 A Study of the Effects of LY3372689 on the Brain in Healthy Participants Status COMPLETED Phase PHASE1
NCT03942042 A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis Status COMPLETED Phase PHASE4
NCT03942029 A Drug Interaction Study of LY3154207 in Healthy Participants Status COMPLETED Phase PHASE1
NCT03940742 A Study of Tirzepatide in Participants With Impaired Liver Function Status COMPLETED Phase PHASE1
NCT03936959 A Study of LY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced Cancer Status TERMINATED Phase PHASE1
NCT03936660 A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease Status COMPLETED Phase NA
NCT03933943 A Study of LY3361237 in Participants With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1